B-Cell Malignant Neoplasm — Trials

B-Cell Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,465 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,083
Recruiting: 1,078
Ph III recruiting: 121
Growth YoY: +5.3%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,167)

clinicaltrialsPublishedShowing 51–100 of 391 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04663347	Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)(EPCORE™ NHL-2)	active not recruiting	Phase 1 / Phase 2	543	GenmabINDUSTRY	13	Sep 9, 2026	clinicaltrials
NCT06311227	Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia	active not recruiting	Phase 2	20	National Cancer Institute (NCI)NIH	1	Sep 9, 2026